135 related articles for article (PubMed ID: 8318176)
1. Effects of zidovudine in 30 patients with mild to end-stage AIDS dementia complex.
Tozzi V; Narciso P; Galgani S; Sette P; Balestra P; Gerace C; Pau FM; Pigorini F; Volpini V; Camporiondo MP
AIDS; 1993 May; 7(5):683-92. PubMed ID: 8318176
[TBL] [Abstract][Full Text] [Related]
2. Presentation and course of AIDS dementia complex: 10 years of follow-up in Amsterdam, The Netherlands.
Portegies P; Enting RH; de Gans J; Algra PR; Derix MM; Lange JM; Goudsmit J
AIDS; 1993 May; 7(5):669-75. PubMed ID: 8318174
[TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal fluid beta 2-microglobulin in patients with AIDS dementia complex: an expanded series including response to zidovudine treatment.
Brew BJ; Bhalla RB; Paul M; Sidtis JJ; Keilp JJ; Sadler AE; Gallardo H; McArthur JC; Schwartz MK; Price RW
AIDS; 1992 May; 6(5):461-5. PubMed ID: 1616651
[TBL] [Abstract][Full Text] [Related]
4. [Risk of the development of dementia after interruption of zidovudine treatment].
Teira R; Uriarte E; Muñoz J; Uterga JM; Sádaba F; Zubero Z; Santamaría JM
Med Clin (Barc); 1998 Sep; 111(9):325-8. PubMed ID: 9810533
[TBL] [Abstract][Full Text] [Related]
5. A follow-up study of neuropsychological functioning in AIDS-patients. Prognostic significance and effect of zidovudine therapy.
Karlsen NR; Reinvang I; Frøland SS
Acta Neurol Scand; 1995 Mar; 91(3):215-21. PubMed ID: 7793239
[TBL] [Abstract][Full Text] [Related]
6. The efficacy and safety of zidovudine alone or as cotherapy with acyclovir for the treatment of patients with AIDS and AIDS-related complex: a double-blind randomized trial. European-Australian Collaborative Group.
Cooper DA; Pehrson PO; Pedersen C; Moroni M; Oksenhendler E; Rozenbaum W; Clumeck N; Faber V; Stille W; Hirschel B
AIDS; 1993 Feb; 7(2):197-207. PubMed ID: 8096703
[TBL] [Abstract][Full Text] [Related]
7. Zidovudine treatment of the AIDS dementia complex: results of a placebo-controlled trial. AIDS Clinical Trials Group.
Sidtis JJ; Gatsonis C; Price RW; Singer EJ; Collier AC; Richman DD; Hirsch MS; Schaerf FW; Fischl MA; Kieburtz K
Ann Neurol; 1993 Apr; 33(4):343-9. PubMed ID: 8489204
[TBL] [Abstract][Full Text] [Related]
8. Zidovudine plus interferon-alpha versus zidovudine alone in HIV-infected symptomatic or asymptomatic persons with CD4+ cell counts > 150 x 10(6)/L: results of the Zidon trial. Zidon Study Group.
Fernández-Cruz E; Lang JM; Frissen J; Furner V; Châteauvert M; Boucher CA; Dowd P; Stevens J
AIDS; 1995 Sep; 9(9):1025-35. PubMed ID: 8527074
[TBL] [Abstract][Full Text] [Related]
9. Methods for detecting early signs of AIDS dementia complex in asymptomatic HIV-1-infected subjects.
Rosci MA; Pigorini F; Bernabei A; Pau FM; Volpini V; Merigliano DE; Meligrana MF
AIDS; 1992 Nov; 6(11):1309-16. PubMed ID: 1361744
[TBL] [Abstract][Full Text] [Related]
10. Neuropsychological characterization of the AIDS dementia complex and rationalization of a test battery.
Maruff P; Currie J; Malone V; McArthur-Jackson C; Mulhall B; Benson E
Arch Neurol; 1994 Jul; 51(7):689-95. PubMed ID: 8018042
[TBL] [Abstract][Full Text] [Related]
11. Rate of CD4 cell decline and prediction of survival in zidovudine-treated patients.
Easterbrook PJ; Emami J; Gazzard B
AIDS; 1993 Oct; 7(10):959-67. PubMed ID: 7903542
[TBL] [Abstract][Full Text] [Related]
12. Mental changes in patients with AIDS.
Derix MM; de Gans J; Stam J; Portegies P
Clin Neurol Neurosurg; 1990; 92(3):215-22. PubMed ID: 2171828
[TBL] [Abstract][Full Text] [Related]
13. Brain growth and cognitive improvement in children with human immunodeficiency virus-induced encephalopathy after 6 months of continuous infusion zidovudine therapy.
DeCarli C; Fugate L; Falloon J; Eddy J; Katz DA; Friedland RP; Rapoport SI; Brouwers P; Pizzo PA
J Acquir Immune Defic Syndr (1988); 1991; 4(6):585-92. PubMed ID: 1673712
[TBL] [Abstract][Full Text] [Related]
14. Long-term zidovudine reduces neurocognitive deficits in HIV-1 infection.
Baldeweg T; Catalan J; Lovett E; Gruzelier J; Riccio M; Hawkins D
AIDS; 1995 Jun; 9(6):589-96. PubMed ID: 7662198
[TBL] [Abstract][Full Text] [Related]
15. Remarkable improvement of neuropsychiatric symptoms in HIV-infected patients after AZT therapy.
Hollweg M; Riedel RR; Goebel FD; Schick U; Naber D
Klin Wochenschr; 1991 Jun; 69(9):409-12. PubMed ID: 1921244
[TBL] [Abstract][Full Text] [Related]
16. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
Siegfried N; van der Merwe L; Brocklehurst P; Sint TT
Cochrane Database Syst Rev; 2011 Jul; (7):CD003510. PubMed ID: 21735394
[TBL] [Abstract][Full Text] [Related]
17. Changing incidence of HIV-induced brain lesions in Oslo, 1983-1994: effects of zidovudine treatment.
Maehlen J; Dunlop O; Liestøl K; Dobloug JH; Goplen AK; Torvik A
AIDS; 1995 Oct; 9(10):1165-9. PubMed ID: 8519453
[TBL] [Abstract][Full Text] [Related]
18. Zidovudine adherence in persons with AIDS. The relation of patient beliefs about medication to self-termination of therapy.
Smith MY; Rapkin BD; Morrison A; Kammerman S
J Gen Intern Med; 1997 Apr; 12(4):216-23. PubMed ID: 9127225
[TBL] [Abstract][Full Text] [Related]
19. Measurement of viral sequences in cerebrospinal fluid of AIDS patients with cerebral white-matter lesions using polymerase chain reaction.
Monno L; Di Stefano M; Zimatore GB; Andreula CF; Appice A; Perulli LM; Fiore JR; Pastore G; Angarano G
AIDS; 1998 Apr; 12(6):581-90. PubMed ID: 9583597
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology of AIDS dementia complex in Europe. AIDS in Europe Study Group.
Chiesi A; Vella S; Dally LG; Pedersen C; Danner S; Johnson AM; Schwander S; Goebel FD; Glauser M; Antunes F
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Jan; 11(1):39-44. PubMed ID: 8528731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
